References and Notes
1a
Evans DA.
Kim AS. In Handbook of Reagents for Organic Synthesis:
Reagents, Auxiliaries and Catalysts for C-C Bonds
Coates RM.
Denmark SE.
John Wiley and Sons;
New
York:
1999.
p.91-101
1b
Seydenpenne J.
Chiral Auxiliaries and Ligands in Asymmetric
Synthesis
Wiley;
New York:
1995.
1c
Ager DJ.
Prakash I.
Schaad DR.
Chem. Rev.
1996,
96:
835
2a
Gregory WA.
Brittelli DR.
Wang CLJ.
Wuonola MA.
McRipley RJ.
Eustice DC.
Eberly
VS.
Bartholomew PT.
Slee AM.
Forbes M.
J. Med. Chem.
1989,
32:
167
2b
Brickner SJ.
Hutchinson DK.
Barbachyn MR.
Manninen PR.
Ulanowicz DA.
Garmon SA.
Crega KC.
Hendges SK.
Toops DS.
Ford CW.
Zurenko GE.
J. Med. Chem.
1996,
39:
673
2c
Park C.-H.
Brittelli DR.
Wang CL.-J.
Marsh FD.
Gregory WA.
Wuonola MA.
McRipley RJ.
Eberly VS.
Slee AM.
Forbes M.
J. Med. Chem.
1992,
35:
1156
3
Jones TK.
Reamer RA.
Desmond R.
Mills SG.
J. Am. Chem.
Soc.
1990,
112:
2998
4
Wouters J.
Curr.
Med. Chem.
1998,
5:
137
5
Sibi MP.
Renhowe PA.
Tetrahedron Lett.
1990,
35:
7407
6a
Pridgen LN.
Prol J.
Alexander B.
Gillyard L.
J. Org. Chem.
1989,
54:
3231
6b
Tamura O.
Hashimoto M.
Kobayashi Y.
Katoh T.
Nakatani K.
Kamada M.
Hayakawa I.
Akiba T.
Terashima S.
Tetrahedron
Lett.
1992,
33:
3487
7a
Sicker D.
Synthesis
1989,
875
7b
Gibson CL.
Gillon K.
Cook S.
Tetrahedron
Lett.
1998,
39:
6733
8
Close WJ.
J.
Am. Chem. Soc.
1951,
73:
95
9a
Ishimaru T.
Nippon Kagaku Zasshi
1960,
81:
1589
9b
Ishimaru T.
Nippon
Kagaku Zasshi
1960,
81:
1428
10
Fu Y.
Baba T.
Ono Y.
J. Catal.
2001,
197:
91
11a
Peng L.
Yuan X.
Wang S.
Lu S.
Tetrahedron
2007,
63:
12419
11b
Liu JM.
Peng XG.
Liu JH.
Zheng
SZ.
Sun W.
Xia CG.
Tetrahedron
Lett.
2007,
48:
929
11c
Wilson T.
J.
Org. Chem.
1986,
51:
2977
11d
Imada Y.
Mitsui Y.
Ike K.
Washizuka K.
Murahashi S.
Bull. Chem.
Soc. Jpn.
1996,
69:
2079
11e
Li F.
Xia C.
J. Catal.
2004,
227:
542
11f
Chiarotto I.
Feroci M.
Tetrahedron Lett.
2001,
42:
3451
11g
Gabriele B.
Brindisi D.
Salerno G.
Costa M.
Chiusoli GP.
Org.
Lett.
2000,
2:
625
11h
Gabriele B.
Mancuso R.
Salerno G.
Costa M.
J. Org. Chem.
2003,
68:
601
11i
Miller AW.
Nguyen ST.
Org. Lett.
2004,
6:
2301
11j
Zheng S.
Li F.
Liu J.
Xia C.
Tetrahedron Lett.
2007,
48:
5883
12a
Dinsmore CJ.
Mercer SP.
Org. Lett.
2004,
6:
2885
12b
Bhanage BM.
Fujita S.
Ikushima Y.
Arai M.
Green Chem.
2003,
5:
340
12c
Tominaga K.-I.
Sasaki Y.
Synlett
2002,
307
13
McGhee W.
Riley D.
Christ K.
Pan Y.
Parnas B.
J.
Org. Chem.
1995,
60:
2820
14
Barton DH.
Elliot JD.
Géro SD.
J. Chem. Soc., Perkin Trans. 1
1982,
2085
15
Boyle PH.
Convery MA.
Davis AP.
Hosken GD.
Murray BA.
J. Chem. Soc., Chem. Commun.
1992,
239
16
García-Egido E.
Fernández-Suárez M.
Muñoz L.
J. Org. Chem.
2008,
73:
2909
17 Purchased from Aldrich chemical company.
18
Representative
Procedure for the Synthesis of 2-Oxazolidinones 4a-j
A
solution of (1S,2R)-norephedrine
(3a, 210 mg, 1.39 mmol) and tetramethylphenylguanidine
(290 mg, 1.52 mmol, 110 mol%) in anhyd MeCN (10 mL) was
cooled to -40 ˚C with a dry ice-acetone
bath. Carbon dioxide was slowly bubbled through the solution for
5 min, and then diphenylphosphoryl azide (DPPA) (0.30 mL, 1.39 mmol,
100 mol%) was added dropwise. Carbon dioxide bubbling was
maintained for a further 15 min, and the reaction mixture was stirred overnight
while it was slowly allowed to reach 20 ˚C. The resulting
solution was concentrated almost to dryness. The residue was dissolved
in CHCl3 (30 mL) and washed with a 10% Na2CO3 (previously
saturated with NaCl) solution (1×). The aqueous layer was
extracted with CHCl3. The combined organic layers were
washed with 1 M HCl (previously saturated with NaCl) solution (1×).
The aqueous layer was further extracted with CHCl3. The
combined organic layers were dried over Na2SO4 and
solvents removed under reduced pressure. The residue was purified
by flash chromatography on SiO2 (hexanes-EtOAc,
4:1 to 2:1) to afford 185 mg of (4R,5S)-4-methyl-5-phenyloxazolidin-2-one
(4a, 75% yield) as a white solid. ¹H
NMR (400 MHz, CDCl3): δ = 7.45-7.27
(m, 5 H), 7.05 (s, 1 H), 5.72 (d, J = 8.1
Hz, 1 H), 4.25 (m, 1 H), 0.83 (d, J = 6.6
Hz, 3 H) ppm. ¹³C NMR (100 MHz, CDCl3): δ = 159.8,
134.8, 128.2, 128.1, 125.7, 80.8, 52.2, 17.2 ppm. IR (NaCl): ν = 3240, 2980,
1756 cm-¹. MS (EI+): m/z (%) = 239
(5) [M+], 107 (100), 104 (23). [α]D
²7 +162
(c 0.50, CHCl3).
(R)-Ethyl 2-Oxothiazolidine-4-carboxylate
(4h): ¹H NMR (400 MHz,
CDCl3): δ = 7.06 (br s, 1 H), 4.39
(ddd, J = 8.4, 4.8,
1.0 Hz, 1 H), 4.18 (q, J = 7.1
Hz, 2 H), 3.64 (dd, J = 11.4,
8.4 Hz, 1 H), 3.51 (dd, J = 11.4,
4.8 Hz, 1 H), 1.23 (t, J = 3 × 7.1
Hz, 3 H) ppm. ¹³C NMR (100 MHz, CDCl3): δ = 174.8,
170.0, 62.0, 55.9, 31.6, 13.8 ppm. IR (NaCl): ν = 3263,
2983, 1741 cm-¹. MS (EI+): m/z (%) = 175
(22), 102 (10), 74 (60). [α]D
²0 -53
(c 3.15, CHCl3).
19 Unpublished results.
20
McGhee W.
Riley D.
J. Org. Chem.
1995,
60:
6205